Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortizatization of IntangiblesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Cash from Operations: 2009-2024

Historic Cash from Operations for Cumberland Pharmaceuticals (CPIX) over the last 16 years, with Dec 2024 value amounting to -$612,186.

  • Cumberland Pharmaceuticals' Cash from Operations fell 60.64% to $187,180 in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 562.80%. This contributed to the annual value of -$612,186 for FY2024, which is 110.05% down from last year.
  • Latest data reveals that Cumberland Pharmaceuticals reported Cash from Operations of -$612,186 as of FY2024, which was down 110.05% from $6.1 million recorded in FY2023.
  • Cumberland Pharmaceuticals' 5-year Cash from Operations high stood at $8.5 million for FY2022, and its period low was -$612,186 during FY2024.
  • Moreover, its 3-year median value for Cash from Operations was $6.1 million (2023), whereas its average is $4.6 million.
  • Its Cash from Operations has fluctuated over the past 5 years, first soared by 77.17% in 2020, then slumped by 110.05% in 2024.
  • Cumberland Pharmaceuticals' Cash from Operations (Yearly) stood at $5.4 million in 2020, then climbed by 17.13% to $6.3 million in 2021, then skyrocketed by 33.28% to $8.5 million in 2022, then decreased by 27.91% to $6.1 million in 2023, then slumped by 110.05% to -$612,186 in 2024.